| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.9 |